TARGET AUDIENCE

This activity is intended for hematologists, hematologists/oncologists, internists, fellows, physician assistants, nurse practitioners, nurses, pharmacists, and all members of the healthcare team who treat or manage patients with acute leukemia and myelodysplastic syndromes.

LEARNING OBJECTIVES

After completing this activity, the participant should be better able to: [LIST] [ITEM]Recognize new developments in MDS and precursor states. [ITEM]Summarize recent insights into the therapeutic and resistance mechanisms of novel therapies in myeloid malignancies. [ITEM]Assess progress in treatment and management strategies for ALL. [ITEM]Deliberate upon improving multidisciplinary care for patients with acute leukemia and myelodysplasia. [ITEM]Evaluate approaches to improve outcomes in the treatment continuum of AML. [ITEM]Appraise strategies to overcome challenges in bone marrow transplantation among patients with acute leukemia. [ITEM]Design individualized treatment plans for diverse patients based on recent progress. [/LIST]

JOINT ACCREDITATION STATEMENTS

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. [JALOGO] [bold]Physician Continuing Medical Education [/bold] The Postgraduate Institute for Medicine designates this live activity for a maximum of 8.5 [italic]AMA PRA Category 1 Credits™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]Continuing Nursing Education [/bold] The maximum number of hours awarded for this Continuing Nursing Education activity is 8.5 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined. [bold]California Board of Registered Nursing [/bold] Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 8.5 contact hours. [bold]Continuing Pharmacy Education [/bold] Postgraduate Institute for Medicine designates this continuing education activity for 8.5 contact hours (.85 CEUs) of the Accreditation Council for Pharmacy Education. [bold]Continuing Physician Assistant Education [/bold] AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™. from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 8.5 Category 1 credits for completing this activity. [bold]ABIM Maintenance of Certification [/bold] [ABIMMOC] Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.5 MOC in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. [bold]Disclosure of Conflicts of Interest[/bold] Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.

[bold]Credit amount subject to change.[/bold]